Fig. 3From: CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic studyCorrelation between CCR5 mRNA expression level and clinicopathological parameters of HNSC patients through the UALCAN database. A Cancer stage (stage 1, 2, 3, and 4). B Patient’s race (Caucasian, African-american, and Asian). C Patient’s gender (male, and female). D Patient’s age. E Tumor Grade (Grade 1, 2, 3, and 4). F Patient’s HPV status. G Nodal metastasis satus (N0 1, 2, and 3). H Patient’s TP53 mutation statusBack to article page